Joël Guigay discusses the ELAN-FIT and ELAN-UNFIT trials in older people with head and neck cancer, published in The Lancet Healthy Longevity, and the importance of geriatric assessments in clinical trials of older cancer patients.

Read the full articles:
https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(23)00284-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhl
https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(24)00048-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhl

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Podden och tillhörande omslagsbild på den här sidan tillhör The Lancet Group. Innehållet i podden är skapat av The Lancet Group och inte av, eller tillsammans med, Poddtoppen.